A carregar...
Do the Metabolic Effects of β Blockers Make Them Leading or Supporting Antihypertensive Agents in the Treatment of Hypertension?
Reduction of blood pressure to guideline goals (i.e., <130/80 mm Hg) in persons with diabetes is crucial to optimally reduce cardiovascular events and kidney disease progression. Since many patients will be >20/10 mm Hg above this goal, most guidelines recommend using agents that block the ren...
Na minha lista:
| Publicado no: | J Clin Hypertens (Greenwich) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Le Jacq Ltd.
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8109409/ https://ncbi.nlm.nih.gov/pubmed/16687944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2005.04679.x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|